albendazole has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saraei, M | 1 |
| Hosseinbigi, B | 1 |
| Shahnazi, M | 1 |
| Bijani, B | 1 |
1 other study available for albendazole and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Fatal Strongyloides hyper-infection in a patient with myasthenia gravis.
Topics: Albendazole; Antinematodal Agents; Endemic Diseases; Fatal Outcome; Humans; Immunocompromised Host; | 2014 |